Screening mammography costs soar for seniors

the ONA take:

Use of new technologies for breast cancer screening has led to substantial increases in cost of screening for older women. In a comparison of data from 2001-2002 and 2008-2009, the use of screening mammography for Medicare-enrolled women without a history of breast cancer was consistent, at approximately 42%. However, the increase in use of more expensive digital mammography technology has resulted in higher costs ($115 vs $73 per mammogram). Overall, Medicare spending on breast cancer screening and related procedures increased from $666 million in 2001-2002 to $962 million in 2008-2009. Unfortunately, the new technology has not been proven more effective in detecting breast cancer in women age 65 years and older. The investigators acknowledge the benefits of screening mammography, but they suggest that screening guidelines specific to older women are needed to minimize unnecessary biopsies and over diagnosis, and to control costs.

Screening mammography costs soar for seniors
Screening mammography costs soar for seniors
The cost of breast cancer screening for older women has soared because of increased use of new technologies, but that hasn't led to earlier detection of breast cancer, a new study shows. But the newer technology has not been shown to be more effective in detecting breast cancer in women aged 65 and older, the Yale School of Medicine researchers said.
READ FULL ARTICLE From CBS News
Loading links....
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs